Condition: Chronic Hypertension Complicating Pregnancy · Pre-Eclampsia · Intrauterine Growth Restriction · Sponsor: Centre Hospitalier Intercommunal Creteil
A randomized clinical trial to assess the efficiency of acetylsalicylic acid (aspirin) 150 mg/day started before 20 weeks of gestation in the prevention on maternal and fœtal complications in pregnant women with chronic hypertension.
This description comes directly from the study's public registry record.
Edouard LE CARPENTIER · 01 45 17 50 00 · Edouard.Lecarpentier@chicreteil.fr
Camille JUNG · 01 45 17 50 00 · camille.jung@chicreteil.fr
Always discuss trial participation with your own doctor first.
| CHU Bordeaux | Bordeaux, France | Recruiting |
| CHU Caen | Caen, France | Withdrawn |
| CHU Antoine Béclère, AP-HP | Clamart, France | Recruiting |
| Hôpital Louis Mourier, AP-HP | Colombes, France | Recruiting |
| Centre Hospitalier Intercommunal de Créteil | Créteil, France | Recruiting |
| CHU Dijon | Dijon, France | Recruiting |
| CHU Bicêtre, AP-HP | Le Kremlin-Bicêtre, France | Recruiting |
| CHRU Lille | Lille, France | Not Yet Recruiting |
| CHU Lyon | Lyon, France | Recruiting |
| Hôpital St Joseph | Marseille, France | Withdrawn |
| CHRU Nancy | Nancy, France | Withdrawn |
| CHU Nantes | Nantes, France | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04356326